APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Selected research

Market Structure

Global Irritable Bowel Syndrome (IBS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025180 pages

Choose your research edition.

Industry ResearchIrritable Bowel Syndrome (IBS) Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Irritable Bowel Syndrome (IBS) Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Irritable Bowel Syndrome (IBS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irritable Bowel Syndrome (IBS) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Irritable Bowel Syndrome (IBS) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

Report Includes

Read the full market overview

This report provides an overview of the global Irritable Bowel Syndrome (IBS) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Irritable Bowel Syndrome (IBS) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Irritable Bowel Syndrome (IBS) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Irritable Bowel Syndrome (IBS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Irritable Bowel Syndrome (IBS) Segment by Company

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Irritable Bowel Syndrome (IBS) Segment by Type

IBS-D Drug

IBS-C Drug

Others

Irritable Bowel Syndrome (IBS) Segment by Application

Women

Men

Irritable Bowel Syndrome (IBS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome (IBS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome (IBS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome (IBS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Irritable Bowel Syndrome (IBS) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Irritable Bowel Syndrome (IBS) industry.

Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irritable Bowel Syndrome (IBS)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of IBS-D Drug Table 3. Key Players of IBS-C Drug Table 4. Key Players of Others Table 4. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Women Table 6. Key Players of Men Table 7. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021-2026) Table 10. Global Irritable Bowel Syndrome (IBS) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2027-2032) Table 12. Irritable Bowel Syndrome (IBS) Industry Trends Table 13. Irritable Bowel Syndrome (IBS) Industry Drivers Table 14. Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges Table 15. Irritable Bowel Syndrome (IBS) Industry Restraints Table 16. Global Irritable Bowel Syndrome (IBS) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2021-2026) Table 18. Global Irritable Bowel Syndrome (IBS) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Irritable Bowel Syndrome (IBS) Key Company Head Office and Area Served Table 20. Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application Table 21. Global Irritable Bowel Syndrome (IBS) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021-2026) Table 28. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2027-2032) Table 29. Global Irritable Bowel Syndrome (IBS) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2021-2026) Table 33. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2027-2032) Table 34. Bausch Health Company Information Table 35. Bausch Health Business Overview Table 36. Bausch Health Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio Table 38. Bausch Health Recent Development Table 39. Allergan Company Information Table 40. Allergan Business Overview Table 41. Allergan Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Allergan Irritable Bowel Syndrome (IBS) Product Portfolio Table 43. Allergan Recent Development Table 44. Takeda Company Information Table 45. Takeda Business Overview Table 46. Takeda Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Takeda Irritable Bowel Syndrome (IBS) Product Portfolio Table 48. Takeda Recent Development Table 49. Sucampo Pharmaceuticals (Mallinckrodt) Company Information Table 50. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview Table 51. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio Table 53. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development Table 54. Sebela Pharmaceuticals Inc Company Information Table 55. Sebela Pharmaceuticals Inc Business Overview Table 56. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio Table 58. Sebela Pharmaceuticals Inc Recent Development Table 59. Astellas Pharmaceuticals Company Information Table 60. Astellas Pharmaceuticals Business Overview Table 61. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio Table 63. Astellas Pharmaceuticals Recent Development Table 64. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 65. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 66. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 67. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 68. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) Table 70. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032) Table 71. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) Table 77. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032) Table 78. China Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 79. China Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 80. China Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 81. China Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) Table 88. Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Irritable Bowel Syndrome (IBS) Product Image Figure 2. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2025 VS 2032 Figure 4. IBS-D Drug Image Figure 5. IBS-C Drug Image Figure 6. Others Image Figure 7. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2025 VS 2032 Figure 9. Women Image Figure 10. Men Image Figure 11. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 13. Global Irritable Bowel Syndrome (IBS) Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021-2032) Figure 20. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2021-2032) Figure 22. North America Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 23. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032) Figure 24. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032) Figure 25. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 26. United States Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 27. Canada Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 29. Europe Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 30. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032) Figure 31. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032) Figure 32. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 33. Germany Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 34. France Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 36. Italy Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 37. Russia Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 39. China Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 40. China Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032) Figure 41. China Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032) Figure 42. Asia Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 43. Asia Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032) Figure 44. Asia Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032) Figure 45. Asia Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 46. Japan Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 50. India Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 51. Australia Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 56. Brazil Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 61. UAE Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 63. Chile Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • IBS-D Drug
  • IBS-C Drug
  • Others
Applications
  • Women
  • Men
Companies covered
  • Bausch Health
  • Allergan
  • Takeda
  • Sucampo Pharmaceuticals (Mallinckrodt)
  • Sebela Pharmaceuticals Inc
  • Astellas Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 IBS-D Drug
  5. 1.2.3 IBS-C Drug
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Women
  10. 1.3.3 Men
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Irritable Bowel Syndrome (IBS) Growth Trends by Region
  13. 1.5.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2026)
  15. 1.5.3 Irritable Bowel Syndrome (IBS) Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Irritable Bowel Syndrome (IBS) Market Dynamics
  1. 2.1 Irritable Bowel Syndrome (IBS) Industry Trends
  2. 2.2 Irritable Bowel Syndrome (IBS) Industry Drivers
  3. 2.3 Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges
  4. 2.4 Irritable Bowel Syndrome (IBS) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Irritable Bowel Syndrome (IBS) Revenue by Company (2021-2026)
  2. 3.2 Global Irritable Bowel Syndrome (IBS) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Irritable Bowel Syndrome (IBS) Key Company Head office and Area Served
  4. 3.4 Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application
  5. 3.5 Global Irritable Bowel Syndrome (IBS) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Irritable Bowel Syndrome (IBS) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Irritable Bowel Syndrome (IBS) Tier 1, Tier 2, and Tier 3
4 Irritable Bowel Syndrome (IBS) Market by Type
  1. 4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2032)
  3. 4.3 Global Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032)
5 Irritable Bowel Syndrome (IBS) Market by Application
  1. 5.1 Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2032)
  3. 5.3 Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bausch Health
  2. 6.1.1 Bausch Health Company Information
  3. 6.1.2 Bausch Health Business Overview
  4. 6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
  6. 6.1.5 Bausch Health Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
  18. 6.3.5 Takeda Recent Developments
  19. 6.4 Sucampo Pharmaceuticals (Mallinckrodt)
  20. 6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
  21. 6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
  22. 6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
  24. 6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
  25. 6.5 Sebela Pharmaceuticals Inc
  26. 6.5.1 Sebela Pharmaceuticals Inc Company Information
  27. 6.5.2 Sebela Pharmaceuticals Inc Business Overview
  28. 6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
  30. 6.5.5 Sebela Pharmaceuticals Inc Recent Developments
  31. 6.6 Astellas Pharmaceuticals
  32. 6.6.1 Astellas Pharmaceuticals Company Information
  33. 6.6.2 Astellas Pharmaceuticals Business Overview
  34. 6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
  36. 6.6.5 Astellas Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  2. 7.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
  3. 7.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
  4. 7.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
  5. 7.2.3 North America Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032)
  6. 7.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
  7. 7.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
  8. 7.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
  9. 7.3.3 North America Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032)
  10. 7.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
  11. 7.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  13. 7.4.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032)
  14. 7.4.4 North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  2. 8.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
  3. 8.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032)
  6. 8.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
  7. 8.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032)
  10. 8.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
  11. 8.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  2. 9.2 China Irritable Bowel Syndrome (IBS) Market Size by Type
  3. 9.2.1 China Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
  4. 9.2.2 China Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
  5. 9.2.3 China Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032)
  6. 9.3 China Irritable Bowel Syndrome (IBS) Market Size by Application
  7. 9.3.1 China Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
  8. 9.3.2 China Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
  9. 9.3.3 China Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  2. 10.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Type
  3. 10.2.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032)
  6. 10.3 Asia Irritable Bowel Syndrome (IBS) Market Size by Application
  7. 10.3.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032)
  10. 10.4 Asia Irritable Bowel Syndrome (IBS) Market Size by Country
  11. 10.4.1 Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst